|
AU3834589A
|
|
Method of treating myeloid leukemias
|
|
AU3740089A
|
|
Human fc-gamma receptor iii
|
|
WO8911489A1
|
|
Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto
|
|
EP0327283A1
|
|
Method of reducing immunoglobulin E responses
|
|
EP0319307A2
|
|
Human Fc-gamma receptor
|
|
DK577388D0
|
|
Humant interleukin -3 and muteines thereof
|
|
IE882311L
|
|
Recovering human interleukin-4 molecule from bacteria
|
|
WO8901046A1
|
|
Purification of human interleukin-4 expressed in escherichia coli
|
|
AU2131688A
|
|
Human granulocyte-macrophage colony stimulating factor and muteins thereof
|
|
CA1335717C
|
|
Human granulocyte-macrophage colony stimulating factor and muteins thereof
|
|
EP0285405A1
|
|
Glycosylation inhibition factors
|
|
IE880432L
|
|
Human interleukin-3 and muteins
|
|
EP0267795A2
|
|
Murine-interleukin-2 muteins
|
|
JPS63146798A
|
|
Human polyfunctional immune factor and mutation protein thereof
|
|
EP0267779A2
|
|
Human pleiotropic immune factor and muteins thereof
|
|
JPS6341498A
|
|
Immunodepressive peptide
|
|
OA9736A
|
|
"Human interleukin-3 and muteins thereof".
|
|
KR930009084B1
|
|
Mammalian interleukin-4
|
|
IE863042L
|
|
Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4)
|
|
EP0200554A2
|
|
Hybridomas producing monoclonal antibodies specific for mouse interleukin-2
|
